Our comprehensive grant program attracts new scientific talent to the field and provides opportunities for researchers to pursue the most novel ideas as well as to advance proven approaches that improve treatment. Advancing fundamental through translational and clinical research.
The Dr. William E. Paul Distinguished Innovator Grant in Lupus and Autoimmunity addresses the current lack of treatments in development that could arrest or reverse the disease. Providing funding for up to $1 million, this grant challenges exceptional scientists to uncover the root causes of lupus and present a compelling vision of how these discoveries would begin the drive to a cure, as well as prevention strategies.
The Novel Research Grant program provides early-stage support with $300,000 grants over three years, used for high-risk, high-reward, idea-driven investigations into the fundamental mechanisms of lupus and its complications, and the explorations of novel targets, pathways, and technologies. The aim is to stimulate the study of underexplored avenues that can lead to the development of safer and more effective treatments.
Under our Target Identification in Lupus (TIL) grant program, investigators receive a three-year, up-to-$600,000 award, to remove the barriers to new treatments and a possible cure. All research funded under the TIL program is is based on realizable goals and designed for “translational” research – discoveries that become useful therapies in the near future, moving quickly from the laboratory to the patient’s bedside.